[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-372001-105":59,"doc-detail-372001-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","platelet-activating-factor-induces-ferroptosis-by-binding-to-atf3-and-inhibiting-the-slc7a11gpx4-axis-to-suppress-the-progression-of-endometrial-carcinoma","Platelet-activating factor induces ferroptosis by binding to ATF3 and inhibiting the SLC7A11/GPX4 axis to suppress the progression of endometrial carcinoma","","Endometrial carcinoma (EC) is an aggressive gynecological malignancy with high recurrence and limited therapeutic options, while patients often show elevated lyso-platelet-activating factor levels; however, how PAF biology and abnormal lyso-PAF relate to EC progression is unclear. This study identifies platelet-activating factor (PAF) as a bioactive mediator that suppresses tumor growth and triggers ferroptosis. Mechanistically, PAF binds ATF3, stabilizes it via deubiquitination, and inhibits the SLC7A11/GPX4 axis to reduce tumor survival, suggesting diagnostic and therapeutic value of PAF metabolism.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/platelet-activating-factor-induces-ferroptosis-by-binding-to-atf3-and-inhibiting-the-slc7a11gpx4-axis-to-suppress-the-progression-of-endometrial-carcinoma/372001/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/platelet-activating-factor-induces-ferroptosis-by-binding-to-atf3-and-inhibiting-the-slc7a11gpx4-axis-to-suppress-the-progression-of-endometrial-carcinoma/372001.png","ImageObject",300,407,{"name":92,"@type":93},"anakgang17","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about PAF in endometrial carcinoma?","Question",{"text":112,"@type":113},"The study examines the biological role of PAF in EC progression and how abnormal lyso-PAF levels relate to EC, which had remained unclear.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does PAF suppress tumor progression according to the results?",{"text":117,"@type":113},"PAF suppresses tumor growth by inducing ferroptosis in vitro and in patient-derived organoid models, supported by mechanistic and in vivo evidence.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular mechanism links PAF to ferroptosis through ATF3 and SLC7A11/GPX4?",{"text":121,"@type":113},"PAF directly binds ATF3, enhances ATF3 stability through deubiquitination, and leads to transcriptional inhibition of SLC7A11 and GPX4 that drives ferroptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},372001,1790216804,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962090883568,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Pan et al. Biology Direct (2026) 21:8 [https://doi.org/10.1186/s13062-025-00713-z](https://doi.org/10.1186/s13062-025-00713-z)  \nBiology Direct  \nRESEARCH Open Access  \nPlatelet-activating factor induces ferroptosis by binding to ATF3 and inhibiting the SLC7A11/GPX4 axis to suppress the progression of endometrial carcinoma  \nFeifei Pan 1,2, Yuqing Qiu 1, Zhuojie Huang3, Yanqin Zheng 1, Yun Chen 1,2, Yiming Song 1, Zhe-Sheng Chen4,  \nLirong Guo 1,2, Jingyao Wang 1,2, Xiaojie Liu5, Zixin Tao6, Yaqiong Liu 1, Xingcui Xuan 1, Kunxiang Gong7* and Kun Shi 1,3*  \nAbstract  \nBackground Endometrial carcinoma (EC) is an aggressive gynecological malignancy with high recurrence ratesand limited treatment options. Patients with EC exhibit elevated serum level s of lyso-platelet-activating factor (lysoPAF), a biologically inactive product generated during the hydrolysis of PAF by PAF-acetyl hydrolase (II) (PAF-AH2) . Nevertheless, the biological function of PAF in EC progression and the relationship between abnormal lyso-PAF levels and EC progression remain unclear.  \nResults In this study, we identified the bioactive phospholipid mediator–PAF, which effectively suppress tumor growth both in vitro and in patient-derived organoid models. By combining the cellular thermal shift assay, drug affinity responsive target stability approach, molecular docking simulation, and surface plasmon resonance analysis, we identified activating transcription factor 3 (ATF3) as the direct binding target of PAF with a Kd of 3 0.24 µM. Mechanistically, PAF enhanced ATF3 stability through deubiquitination. In addition, ATF3 knockdown partially reversed the effects of PAF-induced SLC7A11 and GPX4 transcriptional inhibition. In vivo studies using a nude mouse xenograft model confirmed the ferroptosis-mediated tumor-suppressive effects of PAF, as evidenced by hematoxylin and eosin staining and immunohistochemical analysis. Clinically, proteomic analysis revealed upregulation of PAF-AH2 expression in EC tissues derived from patients. Subsequent analysis of EC tissue microarrays revealed that high  \nPAF-AH2 expression is associated with poor survival.  \nConclusions In conclusion, this study demonstrates that PAF inhibits EC tumor growth by inducing ferroptosisand that the underlying mechanisms of its action involve the targeting of ATF3 . These findings suggest that PAF metabolism may be a promising direction for EC diagnostics and therapeutics.  \nKeywords Endometrial carcinoma, Platelet-activating factor, Ferroptosis, ATF3, PAF-AH2  \n*Correspondence:  \nKunxiang Gong [gkx13265040169@126.com](gkx13265040169@126.com)[ ](gkx13265040169@126.com)Kun Shi [shikun28@hotmail.com](shikun28@hotmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nPan et al. Biology Direct (2026) 21:8  \nBackground  \nEndometrial cancer (EC) is a highly prevalent gynecologic cancer, with 420,242 new cases","cbCaih5eu39miFxP","https://ap.wps.com/l/cbCaih5eu39miFxP","pdf",14234029,"English","# Abstract\n## Background\n## Results\n## Conclusions\n## Keywords\n# Background\n## EC subtype and epidemiology\n## PAF and lyso-PAF biology\n## Ferroptosis overview","[{\"question\":\"What question does the study address about PAF in endometrial carcinoma?\",\"answer\":\"The study examines the biological role of PAF in EC progression and how abnormal lyso-PAF levels relate to EC, which had remained unclear.\"},{\"question\":\"How does PAF suppress tumor progression according to the results?\",\"answer\":\"PAF suppresses tumor growth by inducing ferroptosis in vitro and in patient-derived organoid models, supported by mechanistic and in vivo evidence.\"},{\"question\":\"What molecular mechanism links PAF to ferroptosis through ATF3 and SLC7A11/GPX4?\",\"answer\":\"PAF directly binds ATF3, enhances ATF3 stability through deubiquitination, and leads to transcriptional inhibition of SLC7A11 and GPX4 that drives ferroptosis.\"}]","Platelet-activating factor induces ferroptosis by binding to ATF3 and inhibiting the SLC7A11/GPX4 axis to suppress the progression of endometrial carcinoma | PDF",1790193430,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31bcaaabe791f08f0977505f21ea9496.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/007f099a612068329083bea512cc7ac5.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f97b9c60c403ee8c3d56033f8042c2a7.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/102b65178e941c57dd749814d807a99a.webp",980,1306]